The GLP-1 Bridge Program is a short-term demonstration project that, for the first time, gives Medicare beneficiaries with Part D coverage access to GLP-1 drugs, prescribed for weight loss
doi: 10.3390/ijms22147475 78 van OostveenWMde LangeECM
The high price of brand-name GLP-1 medications is one of the biggest challenges for patients seeking obesity treatment (BMI 30 or more), overweight (BMI 27 or more), and type 2 diabetes mellitus
It is about precision, personalization, and longevity
I work with women every day who are frustrated with weight gain in midlife especially the kind that doesnt budge no matter how clean they eat or how often they work out
15 years of Operation Pangea: over 25 million illegally traded medicines and devices seized in the UK